ANBESOL TEETHING is a brand name for Chlorocresol. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: For the temporary relief of pain caused by recurrent mouth ulcers and denture irritation. For relief of pain and discomfort associated with teething in children from 5 months of age, where non-pharmacological treatments have failed to provide sufficient relief.
Verbatim from this product's MHRA label. Tap a section to expand.
Route of administration: oromucosal Adults and the elderly:
Apply a small amount to the affected area with a clean fingertip. Two applications immediately will normally be sufficient to obtain pain relief. It should not be used more frequently than every 3 hours. 2 grams) of Anbesol teething gel with a clean finger to the affected area.
The dose may be repeated if necessary after 3 hours, up to a maximum of 6 doses in 24 hours. Treatment should be stopped once symptoms have resolved. Not to be used for more than 7 days. Parents or carers should seek medical attention if the child’s condition deteriorates during treatment.
In case of vomiting, spitting or accidental ingestion, the dose should not be repeated immediately. The dose may be repeated if necessary after 3 hours.
Undesirable effects are listed by MedDRA System Organ Classes.
Assessment of undesirable effects is based on the following frequency groupings:
Very common: ≥1/10 Common: ≥1/100 to <1/10 Uncommon: ≥1/1,000 to <1/100 Rare: ≥1/10,000 to <1/1,000 Very rare: <1/10,000 Not known: cannot be estimated from the available data System Organ Class Undesirable Effect Frequency Immune system disorders Allergic reactions Not known Gastrointestinal disorders Non-specific ulceration Not known Skin and subcutaneous tissue disorders Dermatitis Not known Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store.
Do not use more than one product containing lidocaine at the same time. 9). Anbesol should be used with caution in patients with wounds or traumatised mucosa in the region of the proposed application. A damaged mucosa will permit increased systemic absorption resulting in systemic effects, such as convulsions, particularly if excessive quantities are used.
This medicinal product contains chlorocresol and the azo dye Ponceau 4R (E124) which may cause allergic reactions in sensitive individuals. 3 mg/100ml. For comparison, for an adult drinking a glass of wine or 500 ml of beer, the BAC is likely to be about 50 mg/100 ml.
g. propylene glycol or ethanol may lead to accumulation of ethanol and induce adverse effects, in particular in young children with low or immature metabolic capacity.
1. Lidocaine is considered to be unsafe in patients with porphyria because it has been shown to be porphyrinogenic in animals.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Chlorocresol in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.